Global Dermal Fillers Market 2022-2028

Global Dermal Fillers Market 2022-2028

Global Dermal Fillers Market Size, Share, & Analysis by Type (Collagen Fillers, PLLA, HA, CaHA, and Others), and by Application (Fcae-Lift, Lip TREATMENT/ Enhancement, Facial Line Correction Treatment, and Others), and by End-User (Dermatology Clinics and Hospitals) Forecast Period (2022-2028)

Global dermal fillers market is anticipated to grow at a CAGR of 7.3% during the forecast period (2021-2028). The market was valued at $3.9 billion in 2021 which is anticipated to reach nearly $6.8 billion in 2028. The market is driven by growing cosmetic procedures, a rising middle-aged population, and increasing disposable income across the globe. Further, the growing adoption of minimally invasive procedures have increased the number of cosmetic procedures across the globe. The minimally invasive procedure provides faster recovery and better cosmetic results which are contributing to the market growth. As per the International Society of Plastic Surgery (ISAPS), 14.4 million non-surgical procedure were performed in 2021 around the globe. Among these, hyaluronic acid (HA) held 28.1% in 2021, although witnessed a fall of 6.1% compared to 2021. In 2021, as per Aesthetic Plastic Surgery Statistics, surgical procedures were increased by 54.0% and non-surgical procedures were up by 44.0% compared to 2021. As per the American Society of Plastic Surgeons (ASPS), the number of cosmetic procedures is continuously growing as there were around 17.7 million cosmetic procedures performed in the US including surgical and minimally invasive procedures in 2021, which were increased by 2.0% compared to 2017. Among the total cosmetic procedures, around 15.9 million were cosmetic minimally invasive procedures in 2021. Further, the growing minimally invasive procedures have increased the number of cosmetic procedures such as face-lifts, lip treatment, and enhancement, facial line correction treatment, and other treatments such as acne and scar treatment as the minimally invasive procedure provide quick recovery and better cosmetic results which are contributing to the market growth.

Pivotal factors driving the market growth-

 Rising cosmetic procedures

 Growing demand for minimally invasive cosmetic procedures

 Robust R&D investments

 Increase in the aging population

HA fillers held the highest market share of 80.0% in 2021 owing to the increasing adoption of HA fillers for face-lift, lip treatment and enhancement, facial line correction treatment, and other treatments. , In 2021, there were around 4.4 million HA-based minimally invasive cosmetic procedures performed around the globe. The market value for the HA filler segment was $3.1 billion in 2021 and is estimated to reach $5.5 billion in 2028, growing at a CAGR of 7.6% during the forecast period. Collagen fillers, PLLA, CaHA, and other dermal fillers held the least market share of 20.0% in 2021 owing to the increasing adoption of HA dermal fillers alternatives. Various manufacturers such as Allergan PLC, Merz Pharmaceuticals GmbH, and Galderma Laboratories, among others, have been offering branded products such as Captique, Esthélis, Elevess, Hylaform, Juvéderm, Perlane, Prevelle, Puragen, and Restylane for HA dermal fillers. PLLA is estimated to grow at the fastest CAGR of 8.0% during the forecast period. It was valued at $116.0 million in 2021, which is further estimated to reach $214.5 million in 2028. Galderma is working on PLLA dermal fillers owing to its collagen stimulator abilities that enable it to gradually restore the fullness of facial folds and wrinkles.

Based on application, the market is segmented into face-lift, lip treatment/enhancement, facial line correction treatment, and others. Other segments include acne scar treatment. Face-lift held the majority of the market share in the global dermal filler market in 2021. This is due to the increasing adoption of face-lift surgery procedures in Europe. In addition, the rising trend of cosmetic surgery procedures among the middle-aged population to give a youthful appearance is also boosting the market growth. The face-lift segment contributed 46.0% of the market share in 2021 which is further estimated to reach 46.8% in 2028, estimated to account for $3.2 billion in 2028. Moreover, the lip treatment/enhancement segment is anticipated to register the highest CAGR of 7.7% during the forecast period. The segment has a market share of 28.0% in 2021. The growth is attributed to the significant adoption of HA in lip treatment/enhancement applications.

Based on end-user, the market is segmented into dermatology clinics and hospitals. Among these, dermatology clinics are estimated to contribute the highest with a market share of 62.0% in 2021 which accounted for $2.4 billion. This share is further estimated to reach 63.7% in 2028, growing at a CAGR of 7.7% over the forecast period. The highest growth of the segment is attributed to the growing number of dermatology clinics. The growth of the dermatology clinics in the dermal fillers market is backed by the rising number of dermatology clinics. This is due to the rising trend of cosmetic surgery procedures among the middle-aged population to give a youthful appearance. Hospitals are another significant end-user of dermal fillers. Moreover, the hospital segment is followed by dermatology clinics with a total market share of 37.4% in 2021. The dermal fillers in the hospital market are projected to reach $2.5 billion in 2028 from $1.5 billion in 2021, growing at a CAGR of 6.7% during the forecast period.

Based on geography, the study includes economies such as the US, Canada, Brazil, Colombia, Japan, Australia, Russia, India, and UAE. The rest of the world includes the European dermal filler industry, the Chinese dermal filler industry, and other countries. The US held the highest market share of 44.1% in 2021. The US dermal filler market was valued at $1.7 billion in 2021 and is anticipated to reach $2.9 billion in 2028, growing at a CAGR of 7.1% during the forecast period. Procedure-wise, the US, Brazil, Germany, Japan, Turkey, Mexico, Argentina, Italy, Russia, and India, followed by Spain, Greece, Colombia, and Thailand were the top economies in 2021. Whereas, the growth in cosmetic surgery tourism was witnessed in Mexico, Turkey, and Colombia with the highest proportion of foreign patients: 28.2%, 25.8%, and 21.8%, respectively in 2021. The second top economy was Germany in terms of procedures. According to the ISAPS, in 2017, a non-surgical cosmetic injectable procedures in Germany were 364,046 which increased to 695,315 in 2021. Among these injectables, Botulinum Toxin held the highest share of 60.5% in 2017 in non-surgical cosmetic injectable procedures which decreased to 57.6% in 2021. Whereas the hyaluronic acid injectable procedures held 37.9% in 2017 and witnessed an exponential growth and increased to 40.9% in 2021 in Germany. CaHA and PLLA injectable procedures had also observed growth in the number of procedures in 2021.

Various manufacturers such as Allergan PLC, Merz Pharmaceuticals GmbH, and Galderma Laboratories, among others, have been offering branded products such as Captique, Esthélis, Elevess, Hylaform, Juvéderm, Perlane, Prevelle, Puragen, and Restylane for HA dermal fillers. These three players generated around 80% of the market share in 2021. This share is further expected to increase in the near future if the companies continue to cope with internal and external factors affecting their growth in a particular segment. Moreover, the players operating in the market are eying on strengthening their market position to afloat and sustain profitability in the market. These market players are adopting various strategies to capitalize on market opportunities. Mergers and acquisitions, new product launches, geographical expansions, partnerships, and collaborations are some of the key strategies adopted by the market players to stay competitive.